Does it excite you to work with enterprise-wide strategic initiatives in biotech/pharma, and do you have experience with portfolio strategy and corporate transformation? If this sounds like you, and you are ready to take on a broad area of responsibilities, then you could be our new colleague.
Your new position
Zealand is advancing its metabolic health pipeline and entering a pivotal phase of growth and transformation. As Director, Strategy you will lead mission-critical, cross-functional initiatives, drive portfolio prioritization, and ensure enterprise alignment. This senior-facing role partners closely with leadership across R&D and Commercial—as well as executive forums—to turn strategy into execution and measurable impact.
We offer exciting responsibilities:
- Lead large-scale, cross-functional strategic initiatives that advance the portfolio and support corporate transformation.
- Partner with senior leaders across R&D, Commercial, Medical, Finance, and Operations to secure alignment, buy-in, and effective execution.
- Translate scientific, commercial, regulatory, and competitive insights into clear recommendations for portfolio and corporate priorities.
- Drive portfolio governance processes and annual strategic planning cycles to enable data-driven prioritization.
- Own scenario planning and key performance metrics that support enterprise-level strategic decision-making.
- Prepare structured updates and recommendations to the Executive Leadership Team and the Board
Your profile
Thrives in a dynamic biotech environment, integrating scientific and commercial perspectives to create strategic clarity. Communicates with precision, operates with executive presence, and simplifies complexity into actionable direction. Collaborates across functions to align stakeholders and drive measurable outcomes.
- Advanced degree (MBA, PhD, MD, or PharmD) with strong life sciences or business expertise
- Significant experience in biotech/pharma portfolio strategy, corporate strategy, or corporate development
- Proven track record in portfolio governance, strategic planning, and leading complex cross-functional initiatives
- Direct experience partnering with C-suite leaders and preparing or facilitating executive- and Board-level discussions
- Exceptional communication and influence skills, with the ability to align teams across scientific and commercial domains
- Leadership traits suited to an executive-facing role: strategic and structured thinker; highly collaborative and low-ego; confident, concise communicator; outcome-oriented and decisive under ambiguity
Your new team
You will join the Strategy department within Zealand Pharma, working at the intersection of science, commercial strategy, operations, and executive decision-making. The team partners closely with R&D, Commercial, Finance, and Program Leadership and engages regularly with portfolio governance forums, the Executive Leadership Team, and Board preparations.
Let's bond and be bold
We have a unique culture, characterized by excellent teamwork and strong engagement across the organization. And we want you to help us strengthen this culture.
Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other. We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Join us and let's bond and be bold.
Interested in bonding with us? Then please apply no later than December 21, 2025. The applications will be reviewed as they come in. While a cover letter is not required, please include a few sentences in your CV explaining your motivation for applying.
We are committed to an inclusive recruitment process and welcome applications from all job applicants.
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand Pharma have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed products. Zealand Pharma was founded in 1998 and is headquartered in Copenhagen, Denmark, with a team in the U.S. For more information about Zealand Pharma's business and activities, please visit www.zealandpharma.com.
